Influenza Vaccine Market Overview
According to Mordor Intelligence, the Influenza Vaccine Market is estimated at USD 9.38 billion in 2026 and is projected to reach USD 13.46 billion by 2031, registering a CAGR of 7.49% during the forecast period. The market is supported by expanding government-funded immunization programs, pandemic preparedness spending, broader vaccination coverage, and increasing demand for updated vaccine formulations.
The Influenza Vaccine Market size is also being influenced by population aging and the growing need to protect higher-risk groups from seasonal influenza. Manufacturers are expanding beyond traditional production approaches, while healthcare systems are increasing procurement and preparedness programs. These developments are contributing to changing demand patterns across developed and emerging markets.
The Influenza Vaccine industry is also seeing greater interest in cell-based, recombinant, and mRNA-based production platforms. At the same time, consumer-focused formats such as nasal spray vaccines are creating additional opportunities outside conventional clinic-based vaccination.
Report Overview: https://www.mordorintelligence.com/industry-reports/influenza-vaccine-market?utm_source=abnewswire
Key Trends in the Influenza Vaccine Market
Rising Government-Funded Immunization and Procurement
Government-funded immunization programs remain an important factor supporting Influenza Vaccine Market growth. Procurement is increasingly linked not only to seasonal vaccination requirements but also to pandemic preparedness. Governments are building stockpiles and strengthening domestic vaccine manufacturing capabilities to improve readiness for future respiratory disease outbreaks.
Growing Adoption of Cell-Based and Recombinant Production
Manufacturers are increasingly exploring cell-based and recombinant production platforms as alternatives to traditional egg-based manufacturing. These approaches can help address supply concerns and provide manufacturers with additional flexibility when responding to changing influenza strains.
Increasing Demand from Aging Populations
Population aging is supporting demand for influenza vaccines designed for older adults and other higher-risk groups. High-dose and adjuvanted formulations are receiving attention as healthcare systems focus on protecting populations that face greater risks from influenza-related complications.
Greater Focus on Pandemic Preparedness
Pandemic preparedness has become another important area of focus within the Influenza Vaccine Market. Governments and manufacturers are investing in production capacity, stockpiling, and newer vaccine platforms to strengthen their ability to respond to future influenza outbreaks.
This focus is also encouraging manufacturers to develop production systems that can be adjusted more quickly when new strains or pandemic requirements emerge. Such preparedness measures are expected to influence purchasing decisions and capacity planning across the Influenza Vaccine industry.
Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/influenza-vaccine-market?utm_source=abnewswire
Influenza Vaccine Market Segmentation
The Influenza Vaccine Market is segmented by vaccine type, form, age group, route of administration, distribution channel, and geography.
By Vaccine Type
Quadrivalent
Trivalent
High-dose / Adjuvanted
By Form
Inactivated
Live Attenuated
mRNA / Recombinant
By Age Group
Pediatric
Adults
By Route of Administration
Injection
Nasal Spray
By Distribution Channel
Hospitals & Clinics
Pharmacies & Retail Chains
Government & NGO Procurement
By Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Rest of Asia Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East
South America
Brazil
Argentina
Rest of South America
Key Players in the Influenza Vaccine Market
The Influenza Vaccine industry has a concentrated competitive structure, with established pharmaceutical and vaccine manufacturers holding strong positions across major markets. Companies are focusing on vaccine portfolio expansion, alternative manufacturing platforms, pandemic preparedness, and new delivery formats.
Key players operating in the Influenza Vaccine Market include:
CSL Limited
Sanofi
Moderna, Inc.
AstraZeneca plc
GSK plc
The broader competitive landscape also includes Pfizer, Merck & Co., Novavax, Bharat Biotech, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, Emergent BioSolutions, BIKEN, Abbott Laboratories, Viatris, SK bioscience, Green Cross Corp., Valneva, and Mitsubishi Tanabe Pharma.
Conclusion
The Influenza Vaccine Market is expected to continue growing as governments strengthen immunization programs, healthcare systems expand vaccination coverage, and manufacturers invest in pandemic preparedness. Demand from aging populations and higher-risk groups is also supporting the development and use of specialized vaccine formulations.
The Influenza Vaccine Market forecast points to continued opportunities across traditional inactivated vaccines as well as cell-based, recombinant, and mRNA approaches. At the same time, nasal spray vaccination and expanded pharmacy and retail distribution are creating additional ways to reach eligible populations.
Industry Related Reports
Advanced Renal Cell Carcinoma Market The advanced renal cell carcinoma market is projected to grow from USD 9.96 billion in 2026 to USD 13.89 billion by 2031, registering a CAGR of 6.88% during the forecast period. Growth is driven by the increasing burden of kidney cancer, rising demand for targeted and immunotherapy-based treatments, and continued focus on improving outcomes for patients with advanced disease. Get more insights: https://www.mordorintelligence.com/industry-reports/advanced-renal-cell-carcinoma-market?utm_source=abnewswire
Adult Vaccines Market The adult vaccines market is expected to expand from USD 45.84 billion in 2026 to USD 68.54 billion by 2031, at a CAGR of 8.36%. Market growth is supported by increasing awareness of adult immunization, the growing burden of vaccine-preventable diseases, and greater emphasis on preventive healthcare among aging and at-risk populations. Get more insights: https://www.mordorintelligence.com/industry-reports/adult-vaccines-market?utm_source=abnewswire
Ticagrelor Market The ticagrelor market is estimated to grow from USD 1.99 billion in 2026 to USD 2.80 billion by 2031, registering a CAGR of 7.04% during the forecast period. Growth is fueled by the rising prevalence of cardiovascular diseases, increasing demand for antiplatelet therapies, and continued use of ticagrelor in the management of patients at risk of cardiovascular events.
Get more insights: https://www.mordorintelligence.com/industry-reports/ticagrelor-market?utm_source=abnewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:
media@mordorintelligence.com
https://www.mordorintelligence.com/
Media ContactCompany Name: Mordor Intelligence Private LimitedContact Person: Jignesh ThakkarEmail: Send EmailPhone: +1 617-765-2493Address:11th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli City: HyderabadState: Telangana 500008Country: IndiaWebsite: https://www.mordorintelligence.com/
